GMED vs K · P/E 42, rev $1.55B vs P/E 23, $29.03B cap
Globus Medical (GMED) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Globus Medical (GMED) is a medical devices company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported GMED revenue for 2026-06-30 was $1.55B. Net income was $275.9M. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
K does not have a complete income-statement cache yet.
GMED currently screens at market cap $7.66B and trailing P/E 42.1. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the GMED and K stock pages for the full models.
Not investment advice.